pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›cysteine
drug
save

cysteine

Preclinicalupdated 3mo ago
by Baudax Bio Inc
Preclinical
community read0 votes

🐶 often sniffed alongside

top 2
  • tagRecall2 co-mentions · 2 sources
  • drugmannitol1 co-mentions · 1 sources

all catalysts(0)

nothing on the calendar yet

Trials studying cysteine

  • phase2Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBTrecruitingn=102
  • phase4Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patientsrecruitingn=80
  • phase2PK and PD Study of NPI-001 and Cysteamine Bitartraterecruitingn=12
  • phase324-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndromenot yet recruitingn=80
  • phase2Evaluation of the Efficacy of Fomepizole in the Treatment of Acetaminophen Overdoseterminatedn=29
  • N/AUse of a Cysteine-rich Whey Protein Isolate in Post COVID-19 Cognitive Impairmentcompletedn=120
  • phase3A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretionscompletedn=333
  • phase3A Pan-TB Regimen Targeting Host and Microbeactive not recruitingn=352
more trials →

News(0)

no news has mentioned this drug yet

generic
cysteine [INN]
indication
Anesthetic Effect
phase
preclinical
Data sources
ClinicalTrials.gov
last refreshed 40m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?